DGX Filing
4Filing Date: Jul 2, 2026
QUEST DIAGNOSTICS INC (DGX) · Insider Trading (Form 4) SEC Filing
Statement of Changes in Beneficial Ownership
descriptionView SEC Filing
ACC: 0001022079-26-000060open_in_new
Total Value$0
Trades1
Insiders1
Transaction Details
WENTWORTH TIMOTHY C
Director·Direct
Grant · Acquire
Phantom Stock UnitsDerivative
Shares+144
Price$0.00
Total Value$0
Shares Owned After342
Transaction DateJul 1, 2026
Footnotes ▸
Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. | Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.
Post-Transaction Holdings
WENTWORTH TIMOTHY C
| Security | Shares | Change |
|---|---|---|
| Phantom Stock Units | 342 | +144 (72.73%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-07-01
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: QUEST DIAGNOSTICS INC (DGX)
CIK: 0001022079
--- Reporting Owner ---
Name: WENTWORTH TIMOTHY C
CIK: 0001252016
Role: Director
--- Derivative Transactions ---
[Transaction #1]
Security: Phantom Stock Units
Date: 2026-07-01 | Code: A (Grant or award)
Shares: +144 | Price: $0.00
Shares Owned After: 342 | Ownership: D (Direct)
Footnotes:
[F1] Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.
[F1] Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.
--- Footnotes (Complete Index) ---
F1: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.
--- Signature ---
/s/ Sean D. Mersten, Attorney in Fact for Timothy C. Wentworth (2026-07-02)